Interferon dosage form and method therefor
Abstract
Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of about 0.1 to about 5 IU/lb per day by contacting said interferon with oral/pharyngeal mucosa. Interferon is administered in solution or in a novel solid unitary dosage form adapted to be dissolved in saliva when placed in the mouth.
Subject
424/184.1424/85.4
424/85.5
424/85.6
424/85.7
424/464
514/3.7
514/19.2
530/351
A61K 38/21
A61K 38/212
Y10S 435/811
Collections
Citation
Cummins, Joseph M. (2002). Interferon dosage form and method therefor. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /176687.